168 related articles for article (PubMed ID: 34975913)
21. Antiendomysium antibodies in Brazilian patients with celiac disease and their first-degree relatives.
Kotze LM; Utiyama SR; Nisihara RM; Zeni MP; de Sena MG; Amarante HM
Arq Gastroenterol; 2001; 38(2):94-103. PubMed ID: 11793949
[TBL] [Abstract][Full Text] [Related]
22. Fully-automated, chemiluminescence IgA and IgG anti-tissue transglutaminase (tTG) antibodies serum assays for the screening of celiac disease.
Daves M; Cemin R; Perkmann V; Bernard P; Caprioli G; Platzgummer S; Lippi G
J Immunol Methods; 2016 Feb; 429():57-9. PubMed ID: 26773454
[TBL] [Abstract][Full Text] [Related]
23. Antibody Concentrations Decrease 14-Fold in Children With Celiac Disease on a Gluten-Free Diet but Remain High at 3 Months.
Petroff D; Wolf J; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Heiduk M; Flemming G; Schmidt A; Hasenclever D; Mothes T
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1442-1449.e5. PubMed ID: 29654912
[TBL] [Abstract][Full Text] [Related]
24. IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: no evidence for gluten dependency.
Lindfors K; Koskinen O; Laurila K; Collin P; Saavalainen P; Haimila K; Partanen J; Mäki M; Kaukinen K
Clin Chim Acta; 2011 Jun; 412(13-14):1187-90. PubMed ID: 21453693
[TBL] [Abstract][Full Text] [Related]
25. Immune checkpoint inhibitors in mesothelioma: a turning point.
Ceresoli GL; Pasello G
Lancet; 2021 Jan; 397(10272):348-349. PubMed ID: 33485463
[No Abstract] [Full Text] [Related]
26. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.
Vitoria JC; Arrieta A; Arranz C; Ayesta A; Sojo A; Maruri N; García-Masdevall MD
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):571-4. PubMed ID: 10554125
[TBL] [Abstract][Full Text] [Related]
27. Subclinical Celiac Disease Unmasked by Immune Checkpoint Inhibitor Therapy.
Braun DS; Patel S; Schwartz A
J Immunother; 2023 May; 46(4):152-153. PubMed ID: 36780126
[TBL] [Abstract][Full Text] [Related]
28. Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature.
Messer A; Drozd B; Glitza IC; Lu H; Patel AB
Dermatol Online J; 2020 Aug; 26(8):. PubMed ID: 32941716
[TBL] [Abstract][Full Text] [Related]
29. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
[TBL] [Abstract][Full Text] [Related]
30. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
Prevel R; Colin G; Calès V; Renault PA; Mazieres J
Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
[TBL] [Abstract][Full Text] [Related]
31. Immune checkpoint inhibitor-induced diarrhea: Clinicopathological study of 11 patients.
Yanai S; Nakamura S; Kawasaki K; Toya Y; Akasaka R; Oizumi T; Ishida K; Sugai T; Matsumoto T
Dig Endosc; 2020 May; 32(4):616-620. PubMed ID: 31595568
[TBL] [Abstract][Full Text] [Related]
32. Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children.
De Leo L; Villanacci V; Ziberna F; Vatta S; Martelossi S; Di Leo G; Zanchi C; Bramuzzo M; Giudici F; Ventura A; Not T
Gastrointest Endosc; 2018 Sep; 88(3):521-526. PubMed ID: 29807020
[TBL] [Abstract][Full Text] [Related]
33. Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report.
Barera G; Bazzigaluppi E; Viscardi M; Renzetti F; Bianchi C; Chiumello G; Bosi E
Pediatrics; 2001 Jun; 107(6):E93. PubMed ID: 11389291
[TBL] [Abstract][Full Text] [Related]
34. Normalization Time of Celiac Serology in Children on a Gluten-free Diet.
Gidrewicz D; Trevenen CL; Lyon M; Butzner JD
J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):362-367. PubMed ID: 28231071
[TBL] [Abstract][Full Text] [Related]
35. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
[TBL] [Abstract][Full Text] [Related]
36. [Seronegative celiac disease: A case report].
Krums LM; Parfenov AI; Sabelnikova EA; Poleva NI; Bykova SV; Dubtsova EA; Gudkova RB; Khomeriki SG; Rotin DL; Pavlov MV; Starostina NS
Ter Arkh; 2016; 88(2):75-77. PubMed ID: 27030188
[TBL] [Abstract][Full Text] [Related]
37. Severe steroid refractory gastritis induced by Nivolumab: A case report.
Vindum HH; Agnholt JS; Nielsen AWM; Nielsen MB; Schmidt H
World J Gastroenterol; 2020 Apr; 26(16):1971-1978. PubMed ID: 32390707
[TBL] [Abstract][Full Text] [Related]
38. Colitis presenting 5 months after the final dose of anti-PD-1: long-term monitoring is warranted after adjuvant therapy.
Domblides C; Gross-Goupil M; Ravaud A; Poullenot F; Daste A
Immunotherapy; 2021 Jun; 13(9):741-744. PubMed ID: 33906378
[TBL] [Abstract][Full Text] [Related]
39. Nivolumab for the treatment of unresectable pleural mesothelioma.
Hotta K; Fujimoto N; Kozuki T; Aoe K; Kiura K
Expert Opin Biol Ther; 2020 Feb; 20(2):109-114. PubMed ID: 31825692
[No Abstract] [Full Text] [Related]
40. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
